advertisement

Topcon

Editors Selection IGR 16-4

Clinical Forms of Glaucoma: Macular Choroidal Thickness in Pseudoexfoliation

Aakriti G Garg
Gustavo de Moraes

Comment by Aakriti G Garg & Gustavo de Moraes on:

74825 Comparison of macular choroidal thickness in patients with pseudoexfoliation syndrome to normal control subjects with enhanced depth SD-OCT imaging, Moghimi S; Mazloumi M; Johari MK et al., Journal of current ophthalmology, 2017; 29: 258-263


Find related abstracts


Pseudoexfoliation syndrome is an important risk factor for the development of secondary open angle glaucoma and is associated with faster progression to advanced disease.1

Moghimi and colleagues sought to investigate the structural features of the macular choroid in patients with pseudoexfoliation syndrome.2 This cross-sectional study included 32 non-glaucomatous pseudoexfoliation patients with 29 normal controls who underwent enhanced depth imaging spectral domain optical coherence tomography (EDI SD-OCT). This technique captures high resolution images of posterior segment structures, including the choroid and lamina cribrosa.

There was a significant difference between the pseudoexfoliation syndrome group and the normal controls in choroidal volume, central subfield choroidal thickness, inner superior and inner nasal choroidal rings of the EDTDRS grid. However, after adjustment for age, sex, and axial length, these differences were non-significant and macular choroidal thickness and RNFL thickness were similar between groups. Interestingly, although differences in sex, mean axial length and mean age were non-significant (p-values = 0.10, 0.43, 0.52, respectively), they blunt the differences detected in the two groups' choroidal measures in the univariable analysis. The current report agrees with other studies in not finding an independent association between macular choroidal thinning and glaucoma risk factors and/or glaucomatous loss.3-7

The current report agrees with other studies in not finding an independent association between macular choroidal thinning and glaucoma risk factors and/or glaucomatous loss
Additionally, there was a significant negative correlation between age and central subfield choroidal thickness and choroidal volume in the control group, although such an association was not found in pseudoexfoliation syndrome. The association between increasing age and decreasing choroidal thickness is well established,8 therefore it is interesting that this finding was not seen in pseudoexfoliation syndrome group. One possible explanation, as brought up by the authors, is that pseudoexfoliation may have some influence on the effect of aging on choroidal thickness, which resulted in a non-significant relationship between choroidal thickness and age. We also believe this could have been the result of the study selection process, as eyes with pseudoexfoliation syndrome, which is associated with aging, were probably more homogenous in their age distribution. Additionally, pseudoexofoliation syndrome may be associated with accelerated aging of the ocular tissues, which may lead to a thinner choroid independent of the duration of the disease.
Pseudoexofoliation syndrome may be associated with accelerated aging of the ocular tissues, which may lead to a thinner choroid independent of the duration of the disease
Increasing the size of the study and control group is advisable. Additionally, despite excellent agreement between observers, the report did not mention if the measurements were made by observers who were masked to the diagnosis.

In summary, the macular choroidal thickness is thinner in eyes with pseudoexofoliation syndrome (without glaucoma) compared to healthy controls. However, this difference was influenced by confounders such as age, axial length, and sex, resulting in non-significant differences between groups.

References

  1. Leske MC, Heijl A, Hyman L, et al. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 2007;114:1965-1972.
  2. Onda E, Cioffi GA, Bacon DR, Van Buskirk EM. Microvasculature of the human optic nerve. Am J Ophthalmol 1995;120:92-102.
  3. Maul EA, Friedman DS, Chang DS, et al. Choroidal thickness measured by spectral domain optical coherence tomography: factors affecting thickness in glaucoma patients. Ophthalmology 2011;118:1571-1579.
  4. Hosseini H, Nilforushan N, Moghimi S, et al. Peripapillary and macular choroidal thickness in glaucoma. J Ophthalmic Vis Res 2014;9:154-161.
  5. Park HY, Lee NY, Shin HY, Park CK. Analysis of macular and peripapillary choroidal thickness in glaucoma patients by enhanced depth imaging optical coherence tomography. J Glaucoma 2014;23:225-231.
  6. Turan-Vural E, Yenerel N, Okutucu M, Yildiz E, Dikmen N. Measurement of Subfoveal Choroidal Thickness in Pseudoexfoliation Syndrome Using Enhanced Depth Imaging Optical Coherence Tomography. Ophthalmologica 2015;233:204-208.
  7. Moghimi S, Mazloumi M, Johari M, et al. Evaluation of Lamina Cribrosa and Choroid in Nonglaucomatous Patients With Pseudoexfoliation Syndrome Using Spectral-Domain Optical Coherence Tomography. Invest Ophthalmol Vis Sci 2016;57:1293-1300.
  8. Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol 2009;147:811-815.


Comments

The comment section on the IGR website is restricted to WGA#One members only. Please log-in through your WGA#One account to continue.

Log-in through WGA#One

Issue 16-4

Change Issue


advertisement

Oculus